血清甲胎蛋白(AFP)检查是目前应用最广泛的肝癌肿瘤标志物,部分肝癌患者AFP检测结果呈阴性.学者们一直在寻找新的血清肝癌标志物,高尔基体蛋白73(GP73)是一种2型高尔基体膜蛋白.众多研究表明,GP73对肝癌诊断的敏感性和特异性均优于AFP,而核心岩藻糖化GP73则更为理想.因此,GP73与AFP和(或)其他肝癌标志物联合检测可能会大幅度提高早期肝癌的诊断率.%Serum alpha-fetoprotein( AFP )examination is the most widely used tumor marker, but some patients with liver cancer AFP test results were negative. Scholars have been looking for new serum tumor markers of liver cancer. The Golgi protein 73( GP73 )is a type 2 Golgi membrane protein, many studies have shown that GP73 sensitivity and specificity for diagnosis of hepatocarcinoma are better than AFP,while the core fucosylated GP73 is more ideal. So GP73 and AFP and/or other tumor markers combined detection may substantially improve the diagnostic rate of early hepatocarcinoma.
展开▼